Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

David G Hicks

7PUBLICATIONS
3CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Feb 16, 2026
Postradiation angiosarcoma of the breast: a 25-year single-institution analysis of clinicopathological characteristics and immunohistochemical biomarker study.

Kristin J Rybski, Brian S Finkelman, Bin Zhang

|Sep 11, 2024
Optimized biomarker evaluation and molecular testing in the era of breast cancer precision medicine.

David G Hicks, Bradley M Turner

|Feb 11, 2023
The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX<sup>®</sup> Testing.

Bradley M Turner, Brian S Finkelman, David G Hicks

|Feb 11, 2023
The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations.

Brian S Finkelman, Huina Zhang, David G Hicks

|Feb 20, 2022
HER2-low breast cancers: incidence, HER2 staining patterns, clinicopathologic features, MammaPrint and BluePrint genomic profiles.

Huina Zhang, Hani Katerji, Bradley M Turner

|Jun 15, 2019
Risk stratification of ER-positive breast cancer patients: A multi-institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX<sup>®</sup> recurrence score <26.

Bradley M Turner, Mary Ann Gimenez-Sanders, Armen Soukiazian

Pageof 2

Frequent Collaborators

2 joint publications

Huina Zhang

2 joint publications

Brian S Finkelman

1 joint publications

Bin Zhang

Frequent Collaborators

2 joint publications

Huina Zhang

2 joint publications

Brian S Finkelman

1 joint publications

Bin Zhang

Top Related Videos

The <em>In ovo</em> CAM-assay as a Xenograft Model for Sarcoma
12:44

The <em>In ovo</em> CAM-assay as a Xenograft Model for Sarcoma

Published on : Jul 17, 2013

26.3K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on : May 17, 2019

8.9K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on : Aug 01, 2018

8.1K
See more related videos

Top Related Videos

The <em>In ovo</em> CAM-assay as a Xenograft Model for Sarcoma
12:44

The <em>In ovo</em> CAM-assay as a Xenograft Model for Sarcoma

Published on : Jul 17, 2013

26.3K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on : May 17, 2019

8.9K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on : Aug 01, 2018

8.1K
See more related videos